The latest quarterly R&D expense is $2.07 Million with a QoQ Growth of -19.43%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $2.07M.
$2.07M
$2.07 Million
Q2 FY2026 · 2026-06-30
-19.43%
vs. $2.57M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $2.07M | -19.43% | -25.25% |
| Q1 FY2026Period end 2026-03-31 | $2.57M | +20.46% | -20.34% |
| Q4 FY2025Period end 2025-12-31 | $2.13M | -2.22% | -42.22% |
| Q3 FY2025Period end 2025-09-30 | $2.18M | -21.23% | -42.03% |
| Q2 FY2025Period end 2025-06-30 | $2.76M | -14.14% | -36.77% |
| Q1 FY2025Period end 2025-03-31 | $3.22M | -12.63% | -53.06% |
| Q4 FY2024Period end 2024-12-31 | $3.69M | -1.89% | -44.54% |
| Q3 FY2024Period end 2024-09-30 | $3.76M | -14.08% | -34.79% |
| Q2 FY2024Period end 2024-06-30 | $4.37M | -36.26% | -8.47% |
| Q1 FY2024Period end 2024-03-31 | $6.86M | +3.23% | +51.65% |
| Q4 FY2023Period end 2023-12-31 | $6.65M | +15.35% | N/A |
| Q3 FY2023Period end 2023-09-30 | $5.76M | +20.60% | N/A |
| Q2 FY2023Period end 2023-06-30 | $4.78M | +5.60% | N/A |
| Q1 FY2023Period end 2023-03-31 | $4.52M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
